[Ip-health] KEI Comments filed to USTR Special 301 Review

Claire Cassedy claire.cassedy at keionline.org
Thu Feb 9 13:55:46 PST 2017


KEI Comments filed to USTR Special 301 Review

Submitted by Claire Cassedy on 9. February 2017 - 17:53

On February 9, 2017, KEI filed written comments to the Office of the United
States Trade Representative's Special 301 Review process. The Special 301
Review is an annual process carried out by the USTR to, "to identify
countries that deny adequate and effective protection of intellectual
property rights (IPR) or deny fair and equitable market access to U.S.
persons who rely on intellectual property protection."

This year KEI's comments focused on the misleading USPTO data used to
justify increased IP protections, increased transparency in trade policies
and practices, and the need to examine proposals that advocated for
de-linked funding of R&D.

This year's Special 301 Review in particular presents an opportunity for
the new administration has to reassess USTR policies and approaches, and
going forward, to emphasize the interests of American citizens when
establishing global IP norms and policies.

KEI also filed notice of intent to testify at the Special 301 Review
Hearing. The hearing will take place on Wednesday, March 8th, 2017.

[1] http://keionline.org/sites/default/files/KEI-2017Special301Review.pdf

More information about the Ip-health mailing list